Insecticides (India) Ltd Q4 FY26 Results

Insecticides (India) Limited has announced its financial results for the fourth quarter and year ended March 31, 2026. The company reported a notable increase in revenue for the period, though its consolidated net profit saw a decline compared to the previous year.

Reader Takeaway: Revenue growth is positive, but watch consolidated profit margins.

What just happened

For the quarter ended March 31, 2026:

• Standalone Revenue: ₹427.96 crore (up from ₹362.08 crore in Q4 FY25)
• Standalone Net Profit: ₹14.36 crore (up from ₹14.02 crore in Q4 FY25)
• Consolidated Revenue: ₹426.26 crore (up from ₹361.78 crore in Q4 FY25)
• Consolidated Net Profit: ₹11.71 crore (down from ₹13.89 crore in Q4 FY25)

The board also approved the formulation of the IIL ESPS Scheme 2026, which allows for the allotment of up to 2,00,000 equity shares to eligible employees, pending shareholder approval. Mrs. Nikunj Aggarwal resigned as Whole Time Director, and Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director.

Why this matters

The contrasting performance between standalone and consolidated profits highlights potential operational challenges or impacts from subsidiary performance on the group's overall profitability. While top-line growth is encouraging, the dip in consolidated net profit warrants investor attention to understand the factors affecting margins.

The backstory

Insecticides (India) Limited is a significant player in the agrochemical sector. The company's performance is closely tied to agricultural cycles and government policies related to crop protection. Over the past couple of years, the sector has navigated supply chain challenges and evolving demand patterns.

What changes now

The approved ESPS 2026 scheme aims to incentivize employees and align their interests with the company's long-term growth. The leadership changes, particularly the appointment of Mr. Sanskar Aggarwal, suggest a focus on future strategy and succession planning. Investors will be keen to see how the company addresses the factors impacting its consolidated profitability.

Risks to watch

Any significant decline in consolidated net profit can impact investor sentiment. External factors like monsoons, raw material price fluctuations, and regulatory changes in the agrochemical industry also pose risks. The company needs to ensure its subsidiaries contribute positively to the overall bottom line.

Peer comparison

Insecticides India operates in a competitive agrochemical market with players like UPL, Rallis India, and PI Industries. While a direct comparison of Q4 results needs detailed financial analysis, revenue growth across the sector has been a mixed bag, influenced by demand and input costs.

Context metrics (time-bound)

• Standalone revenue grew approximately 18.2% year-on-year in Q4 FY26.
• Consolidated revenue grew approximately 17.8% year-on-year in Q4 FY26.
• Standalone profit grew approximately 2.4% year-on-year in Q4 FY26.
• Consolidated profit declined approximately 15.7% year-on-year in Q4 FY26.

What to track next

Investors should monitor the company's ability to improve consolidated profit margins in the upcoming quarters. The successful implementation of the ESPS 2026 and the strategic direction under the new director will also be key points to track.